Petra Capital Reaffirms Their Buy Rating on IPH Ltd. (IPH)
In a report released today, Sam Haddad from Petra Capital maintained a Buy rating on IPH Ltd. (IPH – Research Report), with a price target of A$8.00. The company's shares closed today at A$4.80.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Haddad is a 4-star analyst with an average return of 10.8% and a 53.92% success rate. Haddad covers the Consumer Cyclical sector, focusing on stocks such as Myer Holdings Limited, Temple & Webster Group Ltd, and Premier Investments Limited.
Currently, the analyst consensus on IPH Ltd. is a Moderate Buy with an average price target of A$7.38.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
20 minutes ago
- Business Insider
Bowhead Specialty files $300M mixed securities shelf
17:03 EDT Bowhead Specialty (BOW) files $300M mixed securities shelf Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Business Insider
20 minutes ago
- Business Insider
Amaze files to sell 44.62M shares of common stock for holders
16:50 EDT Amaze (AMZE) files to sell 44.62M shares of common stock for holders Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Business Insider
an hour ago
- Business Insider
DocMorris (DOCM) Receives a Hold from ZKB
DocMorris (DOCM – Research Report) received a Hold rating and price target from ZKB analyst today. The company's shares closed today at CHF7.61. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Currently, the analyst consensus on DocMorris is a Moderate Buy with an average price target of CHF18.20. Based on DocMorris' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF520.76 million and a GAAP net loss of CHF59.32 million. In comparison, last year the company earned a revenue of CHF506.51 million and had a GAAP net loss of CHF59.33 million
